Literature DB >> 19700791

Proteome, phosphoproteome, and hydroxyproteome of liver mitochondria in diabetic rats at early pathogenic stages.

Wen-Jun Deng1, Song Nie, Jie Dai, Jia-Rui Wu, Rong Zeng.   

Abstract

It has been proposed that mitochondrial dysfunction is involved in the pathogenesis of type 2 diabetes (T2D). To dissect the underlying mechanisms, we performed a multiplexed proteomics study on liver mitochondria isolated from a spontaneous diabetic rat model before/after they were rendered diabetic. Altogether, we identified 1091 mitochondrial proteins, 228 phosphoproteins, and 355 hydroxyproteins. Mitochondrial proteins were found to undergo expression changes in a highly correlated fashion during T2D development. For example, proteins involved in beta-oxidation, the tricarboxylic acid cycle, oxidative phosphorylation, and other bioenergetic processes were coordinately up-regulated, indicating that liver cells confronted T2D by increasing energy expenditure and activating pathways that rid themselves of the constitutively increased flux of glucose and lipid. Notably, activation of oxidative phosphorylation was immediately related to the overproduction of reactive oxygen species, which caused oxidative stress within the cells. Increased oxidative stress was also evidenced by our post-translational modification profiles such that mitochondrial proteins were more heavily hydroxylated during T2D development. Moreover, we observed a distinct depression of antiapoptosis and antioxidative stress proteins that might reflect a higher apoptotic index under the diabetic stage. We suggest that such changes in systematic metabolism were causally linked to the development of T2D. Comparing proteomics data against microarray data, we demonstrated that many T2D-related alterations were unidentifiable by either proteomics or genomics approaches alone, underscoring the importance of integrating different approaches. Our compendium could help to unveil pathogenic events in mitochondria leading to T2D and be useful for the discovery of diagnosis biomarker and therapeutic targets of T2D.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19700791      PMCID: PMC2808256          DOI: 10.1074/mcp.M900020-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  60 in total

1.  Expanded coverage of the human heart mitochondrial proteome using multidimensional liquid chromatography coupled with tandem mass spectrometry.

Authors:  Sara P Gaucher; Steven W Taylor; Eoin Fahy; Bing Zhang; Dale E Warnock; Soumitra S Ghosh; Bradford W Gibson
Journal:  J Proteome Res       Date:  2004 May-Jun       Impact factor: 4.466

Review 2.  Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis.

Authors:  F G Hegardt
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

3.  Systematic identification of human mitochondrial disease genes through integrative genomics.

Authors:  Sarah Calvo; Mohit Jain; Xiaohui Xie; Sunil A Sheth; Betty Chang; Olga A Goldberger; Antonella Spinazzola; Massimo Zeviani; Steven A Carr; Vamsi K Mootha
Journal:  Nat Genet       Date:  2006-04-02       Impact factor: 38.330

Review 4.  [Abnormalities in lipid metabolism associated with diabetes mellitus].

Authors:  Y Iizuka; T Murase; Y Iizuka
Journal:  Nihon Rinsho       Date:  1997-10

Review 5.  Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in type II diabetes.

Authors:  C B Wollheim
Journal:  Diabetologia       Date:  2000-03       Impact factor: 10.122

6.  Renal mitochondrial damage and protein modification in type-2 diabetes.

Authors:  Ganesh K Kartha; Karni S Moshal; Utpal Sen; Irving G Joshua; Neetu Tyagi; Mesia M Steed; Suresh C Tyagi
Journal:  Acta Diabetol       Date:  2008-06       Impact factor: 4.280

7.  Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.

Authors:  R V Farese; M L Standaert; K Yamada; L C Huang; C Zhang; D R Cooper; Z Wang; Y Yang; S Suzuki; T Toyota
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin.

Authors:  Damien Demozay; Stéphane Rocchi; Jean-Christophe Mas; Sophie Grillo; Luciano Pirola; Carine Chavey; Emmanuel Van Obberghen
Journal:  J Biol Chem       Date:  2003-11-24       Impact factor: 5.157

9.  A mitochondrial protein compendium elucidates complex I disease biology.

Authors:  David J Pagliarini; Sarah E Calvo; Betty Chang; Sunil A Sheth; Scott B Vafai; Shao-En Ong; Geoffrey A Walford; Canny Sugiana; Avihu Boneh; William K Chen; David E Hill; Marc Vidal; James G Evans; David R Thorburn; Steven A Carr; Vamsi K Mootha
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

10.  Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients.

Authors:  Toshinari Takamura; Hirofumi Misu; Naoto Matsuzawa-Nagata; Masaru Sakurai; Tsuguhito Ota; Akiko Shimizu; Seiichiro Kurita; Yumie Takeshita; Hitoshi Ando; Masao Honda; Shuichi Kaneko
Journal:  Obesity (Silver Spring)       Date:  2008-10-09       Impact factor: 5.002

View more
  49 in total

Review 1.  VDAC proteomics: post-translation modifications.

Authors:  Janos Kerner; Kwangwon Lee; Bernard Tandler; Charles L Hoppel
Journal:  Biochim Biophys Acta       Date:  2011-11-19

2.  Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome.

Authors:  Tiannan Guo; Sze Sing Lee; Wai Har Ng; Yi Zhu; Chee Sian Gan; Jiang Zhu; Haixia Wang; Shiang Huang; Siu Kwan Sze; Oi Lian Kon
Journal:  Cell Mol Life Sci       Date:  2010-10-16       Impact factor: 9.261

Review 3.  Mitochondria in the pathogenesis of diabetes: a proteomic view.

Authors:  Xiulan Chen; Shasha Wei; Fuquan Yang
Journal:  Protein Cell       Date:  2012-06-22       Impact factor: 14.870

4.  The L279P mutation of nuclear distribution gene C (NudC) influences its chaperone activity and lissencephaly protein 1 (LIS1) stability.

Authors:  Xiao-Jing Zhu; Xunyan Liu; Qi Jin; Yuqi Cai; Yuehong Yang; Tianhua Zhou
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

5.  A quantitative map of the liver mitochondrial phosphoproteome reveals posttranslational control of ketogenesis.

Authors:  Paul A Grimsrud; Joshua J Carson; Alex S Hebert; Shane L Hubler; Natalie M Niemi; Derek J Bailey; Adam Jochem; Donald S Stapleton; Mark P Keller; Michael S Westphall; Brian S Yandell; Alan D Attie; Joshua J Coon; David J Pagliarini
Journal:  Cell Metab       Date:  2012-11-07       Impact factor: 27.287

6.  Protein sets define disease states and predict in vivo effects of drug treatment.

Authors:  David Meierhofer; Christopher Weidner; Ludger Hartmann; Johannes A Mayr; Chung-Ting Han; Frank C Schroeder; Sascha Sauer
Journal:  Mol Cell Proteomics       Date:  2013-04-11       Impact factor: 5.911

7.  Macrophage infiltration promotes invasiveness of breast cancer cells via activating long non-coding RNA UCA1.

Authors:  Shuzheng Chen; Chuxiao Shao; Min Xu; Jiansong Ji; Yanru Xie; Yongliang Lei; Xiaoguang Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 8.  Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure.

Authors:  Brian O'Rourke; Jennifer E Van Eyk; D Brian Foster
Journal:  Congest Heart Fail       Date:  2011-11-09

9.  A metabonomic comparison of urinary changes in Zucker and GK rats.

Authors:  Liang-Cai Zhao; Xiao-Dong Zhang; Shi-Xian Liao; Hong-Chang Gao; He-Yao Wang; Dong-Hai Lin
Journal:  J Biomed Biotechnol       Date:  2010-10-13

10.  Proteomic characteristics of the liver and skeletal muscle in the Chinese tree shrew (Tupaia belangeri chinensis).

Authors:  Rongxia Li; Wei Xu; Zhen Wang; Bin Liang; Jia-Rui Wu; Rong Zeng
Journal:  Protein Cell       Date:  2012-08-12       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.